Veru, Inc. (VERU)
2.29
+0.07
(+3.15%)
USD |
NASDAQ |
May 22, 11:06
Veru Cash from Investing (Quarterly) : 3.520M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -11.32M |
| Corcept Therapeutics, Inc. | 4.542M |
| Assertio Holdings, Inc. | 15.11M |
| IGC Pharma, Inc. | -0.17M |
| Johnson & Johnson | -1.04B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.915M |
| Free Cash Flow | -26.06M |
| Free Cash Flow Per Share (Quarterly) | -0.3868 |
| Free Cash Flow to Equity (Quarterly) | -8.771M |
| Free Cash Flow to Firm (Quarterly) | -8.915M |
| Free Cash Flow Yield | -62.63% |